The latest craze to cure farts, or coughs, is a form of “fart blizzard medicine” that uses a frozen sample of the fluid to cure the disease.
But a new report from The Lancet describes the use of this medicine in a way that could cause serious harm.
This could be a problem for people who already have a condition or for people with compromised immune systems.
The new report, published online in The Lancet, is based on clinical data from the UK, the US and Israel.
It says: “The use of frozen samples of the faecal matter of people with bronchitis or other coughs could be potentially harmful, as these products are designed to contain fluid.”
In the UK and the US, where there are currently no clinical trials for the product, a spokeswoman for the British Fungal Disease Association told The Guardian that it had “no scientific evidence to support this product”.
In the US the Fungus Institute for Science and Technology, which promotes the use and testing of new products, said it did not have any information about the use in the US.
The British Fong Health Council said it had not yet received any information from the US about its products.
Fart-blizzard medicine is a new idea for doctors who have not used existing treatments for other conditions such as cancer or tuberculosis.
It is also a popular treatment for those with bronchiectasis, a rare condition that affects the spleen, kidneys and lungs.
“There’s no proven benefit in this form of therapy,” said Dr Richard Beechey, a paediatrician at London’s Imperial College Hospital.
“We’re just not doing enough testing.”
This is the first time Fart Blizzard Medicine has been used to treat a condition in the UK.
Farts are caused by bacteria, viruses and fungi, and they are transmitted from person to person through coughing, sneezing or spitting.
This can be as mild as a cough, or as severe as a bout of pneumonia.
People who have a history of farts have a higher risk of developing respiratory infections, including asthma and pneumonia.
Fasting causes the release of fluid called mucus from the nose.
This is what causes the farts to come out.
The researchers looked at samples of faeces from more than 6,000 people in the United Kingdom, the United States, Israel and the UK who had been tested for the bacteria, and found that the samples contained antibodies against the bacteria that the researchers had previously found in human faecalis.
In one sample, for example, the bacteria had been detected in the mucus of at least four people.
The samples had been collected between April and July 2016.
The UK has had a number of other fad products available for a few years now, including a “fertiliser” that used faecanese, and a product that could be used to clean farts and produce a “breath freshener” that could help the immune system recover from infection.
The Lancet report does not say how the product was developed or what tests were carried out to determine its safety.
The company behind the product is called Medicinal Genetics and was established in 2009.
It has produced products containing faecally produced products for some years, but not this one.
Medicinal Genomics is one of the few firms to be licensed in the country, and has been producing products since 2009.
However, this is the latest development.
Fungi researchers and other scientists said they were concerned that the new product would cause significant harm.
“This is a product which is designed to be injected into the body, not used in the clinic. “
“If it is used as an antibiotic, the patient is going to die. “
“It’s just a horrible idea. “
I don’t think anybody would take this seriously. “
It’s just a horrible idea.
Dr Breen added that the research into the effects of FartBlizzard Medicine would be interesting, but that it would not be useful. “
People are going to think: ‘I wonder what they’ve done to the bacteria in my guts?'”
Dr Breen added that the research into the effects of FartBlizzard Medicine would be interesting, but that it would not be useful.
He said: The product has never been tested on animals.
“You have to ask how much of the product are you going to inject and how long the time it’s in the patient’s body, and how many bacteria are you taking into the patient.”
The UK Funga Disease Association said: We are aware of a recent case where an adult with bronchoalveolar pneumonia and bronchiolitis had developed fever, headache and chest pain.
“However, it is important to note that the cause of the fever and chest pains